NSRX (nasuspharma.com) יחס שווי שוק לשווי בספרים

Nasus Pharma Ltd (NSRX) develops nasal inhalers in compliance with medical plastic disposal standards. The technological foundation relies on the automation of conveyors and dispensers, which reduces personnel costs. This chart shows the current share price on GURU.Markets is 10.51. However, potential patent conflicts, challenges in expanding capacity, and the possibility of failure during clinical trials of a narrow product portfolio undermine revenue stability.

This metric is calculated as the ratio of the total market capitalization of all shares to the company's net equity. It determines the premium that investors are willing to pay over the business's assets. For Nasus Pharma Ltd (NSRX), this calculation is critical due to the systematic consumption of liquidity for clinical trials. The decline in book value amid a lack of revenue makes the company's P/BV ratio extremely sensitive. The trend of this indicator reflects market confidence in the future success of its drugs.